¼¼°èÀÇ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå ¿¹Ãø(-2029³â) : ÃÖÁ¾ Á¦Ç° À¯Çüº°, Àåºñ À¯Çüº°, Áö¿ªº°
Pharmaceutical Manufacturing Equipment Market by Machine (Mixing & Blending, Milling, Spray Drying, Granulation, Extrusion, Tablet Compression, Sterilization, and Inspection), Process (Encapsulation, Formulation, Aseptic) - Global Forecast to 2029
»óǰÄÚµå : 1614458
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 247 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,781,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,111,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,166,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,701,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå ±Ô¸ð´Â 2024³â 194¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2029³â¿¡´Â 269¾ï 4,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£ Áß CAGRÀº 6.8%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¦³×¸¯ ÀǾàǰ ¼ö¿äÀÇ Áõ°¡°¡ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ¸®ÆÛºê ÀåºñÀÇ ¼ö¿ä°¡ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³â 2020-2029³â
±âÁسâ 2023³â
¿¹Ãø ±â°£ 2024-2029
°ËÅä ´ÜÀ§ ±Ý¾×(10¾ï ´Þ·¯)
ºÎ¹®º° ÃÖÁ¾ Á¦Ç° À¯Çüº°, Àåºñ À¯Çüº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ±âŸ Áö¿ª

Æ÷Àå±â ºÎ¹®Àº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÎÇØ Á¦¾à Á¦Á¶ Àåºñ ½ÃÀå¿¡¼­ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÁ¸®ÇÊµå ½Ã¸°Áö, 1ȸ¿ë ¹ÙÀ̾Ë, ºí¸®½º ÅÍ ÆÑ°ú °°Àº Çõ½ÅÀûÀÎ ¾à¹°Àü´Þ ÇüÅ´ Á¦¾à »ê¾÷¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ÷´Ü Á¤±³ÇÑ Æ÷Àå ¼Ö·ç¼ÇÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϷùøÈ£ ºÎ¿© ¹× º¯Á¶ ¹æÁö ¼Ö·ç¼Ç°ú °°Àº ÷´Ü Æ÷Àå ±â¼úÀÇ Ã¤ÅÃÀº ÀǾàǰÀÇ ¾ÈÀü¼º°ú ÃßÀû¼º¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ Á᫐ ÀÇ·á Áõ°¡ Ãß¼¼¿¡ µû¶ó Æ÷ÀåÀº »ç¿ëÀÚÀÇ ÆíÀǼº°ú ÄÄÇöóÀ̾𽺸¦ Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦, ¸ÂÃãÇü ÀǾàǰ ¹× ¹é½ÅÀÇ ¼ºÀå ¶ÇÇÑ °íÁ¤¹Ð ¹«±Õ Æ÷Àå ȯ°æÀ» ÇÊ¿ä·Î ÇϹǷΠ÷´Ü Æ÷Àå ±â°è¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¾×»ó ºÎ¹®Àº ¼Ò¾Æ ÀǾàǰ¿¡ ´ëÇÑ ±ÔÁ¦ °­È­·Î ÀÎÇØ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)ÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú °°Àº ±ÔÁ¦±â°üÀº ¾î¸°À̵éÀÌ Á¤Á¦³ª ĸ½¶°ú °°Àº °íÇüÁ¦¸¦ »ïų ¶§ Á÷¸éÇÏ´Â ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ¿¬·É¿¡ ¸Â´Â ¾×ü ÀǾàǰÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº ¼Ò¾Æ Ä¡·áÀÇ ¼øÀÀµµ, ¾ÈÀü¼º, À¯È¿¼ºÀ» Çâ»ó½Ã۰í, ¾×ü Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾×»ó ÀǾàǰÀº Á¤È®ÇÑ Åõ¿©°¡ °¡´ÉÇϹǷΠ¼Ò¾Æ ¹× ±âŸ ȯÀÚ ¸ÂÃãÇü Åõ¿©°¡ ÇÊ¿äÇÑ °æ¿ì¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¼Ò¾Æ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¦¾à»çµéÀº ¾×»ó Á¦Çü¿¡ ´ëÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ »õ·Î¿î ½ÃÀå ±âȸ¸¦ ¸ð»öÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Áö¿ªÀº ´ëÇü Á¦¾àȸ»ç¿Í Áß¼Ò±â¾÷ÀÌ ¸ðµÎ Áö¹èÇÏ´Â °æÀïÀÌ Ä¡¿­Çϸç, ±× °á°ú Á¦Ç° Çõ½Å°ú ´Ù¾çÈ­°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î Á¦Á¶ ±â¼úÀ» À§ÇÑ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ°¡ ÀÌ Áö¿ª ½ÃÀå ¿ìÀ§¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰÀº À¯·´ Àü¿ª¿¡ º¯È­¸¦ ÃÊ·¡ÇÏ´Â »ê¾÷Àû º¯È­¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. µ¶ÀÏÀº EU¿¡¼­ ½ÂÀÎµÈ ¹ÙÀÌ¿ÀÀǾàǰ ¹°ÁúÀÇ ÃÖ´ë »ý»ê±¹ÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰÀÇ ¸ÅÃâ Áõ°¡¿Í ÀÏÄ¡ÇÏ¿© À¯·´ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ÃÖÁ¾ Á¦Ç° À¯Çüº°, Àåºñ À¯Çüº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ÀǾàǰ Á¦Á¶ Àåºñ °ø±Þ¾÷ü¿Í ¾ÖÇÁÅ͸¶ÄÏ °ø±Þ¾÷ü

Á¦7Àå ÀǾàǰ ±â±âÀÇ ÁÖ¿ä Á¦Á¶ °øÁ¤

Á¦8Àå ÀǾàǰ Á¦Á¶ Àåºñ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå, ÃÖÁ¾ Á¦Ç° À¯Çüº°

Á¦10Àå ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå, Àåºñ À¯Çüº°

Á¦11Àå ÀǾàǰ Á¦Á¶ Àåºñ ½ÃÀå, Áö¿ªº°

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period. Rising demand for generic drugs is driving the growth of the pharmaceutical manufacturing equipment market. Whereas the demand for refurbished equipments is restraining the growth of the pharmaceutical manufacturing equipment market.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy equipment type, end-product type, process, end user, supplier type, and region
Regions coveredNorth America, Europe, APAC, RoW

"Packaging machines segment is expected to witness highest CAGR during the forecasted period in pharmaceutical manufacturing equipment market."

The packaging machines segment is expected to have the highest CAGR in the pharmaceutical manufacturing equipment market due to a few critical factors. Innovative drug delivery formats such as pre-filled syringes, single-dose vials, and blister packs are gaining much importance in the pharmaceutical industry, which requires advanced and sophisticated packaging solutions. In addition, adoption of sophisticated packaging technologies, such as serialization and tamper-evident solutions, is stringent regulatory requirements for drug safety and traceability. It is also due to the growing trend of patient-centric healthcare, where packaging is playing an important role in enhancing user convenience and compliance. The growth in biologics, personalized medicines, and vaccines also requires highly precise and sterile packaging environments, thereby further driving demand for advanced packaging machines.

"Liquid segment is likely to witness highest CAGR in pharmaceutical manufacturing equipment market during forecasted period ."

The liquid segment is witnessing the CAGR due to regulatory emphasis on pediatric formulations. Regulatory bodies such as the US Food and Drug Administration (FDA) have stressed the need for age-appropriate liquid medications to address the challenges children face with swallowing solid forms like tablets and capsules. This push ensures better compliance, safety, and efficacy in pediatric treatments, significantly driving demand for liquid dosage forms. Additionally, liquid medications allow precise dosing, making them ideal for children and other patients requiring tailored administration. The growing focus on pediatric health has led pharmaceutical companies to innovate in liquid formulations, opening new market opportunities.

"Europe is expected to hold the second largest market share of the pharmaceutical manufacturing equipment market during forecasted period".

The region is marked by a very competitive landscape, dominated by both large pharmaceutical companies and SMEs, thus facilitating innovation and diversification in terms of products. A tremendous investment in R&D for new manufacturing technologies supports the region's dominance in this market. Biopharmaceuticals form a great shift in the industry and have transformed it across Europe; Germany has emerged to be the largest producer of EU-approved biopharmaceutical substances. This growth is matched by increasing revenues from biologics, which further strengthens the the pharmaceutical manufacturing equipment market in Europe.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

The pharmaceutical manufacturing equipment market is dominated by a few globally established players such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), Korber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany). The study includes an in-depth competitive analysis of these key players in the pharmaceutical manufacturing equipment market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the pharmaceutical manufacturing equipment and forecasts its size by equipment type, end product type, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It gives a detailed view of the market across four main regions-North America, Europe, Asia Pacific, and RoW. Supply chain analysis has been included in the report, along with the key players and their competitive analysis in the pharmaceutical manufacturing equipment ecosystem.

Key Benefits to Buy the Report:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 PHARMACEUTICAL MANUFACTURING EQUIPMENT SUPPLIERS AND AFTERMARKET SUPPLIERS

7 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES

8 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

9 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

10 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â